Diferencia entre revisiones de «Sexually transmitted diseases»
Sin resumen de edición |
Sin resumen de edición |
||
| Línea 1: | Línea 1: | ||
== Chart == | == Chart == | ||
{| style="border: medium none; | {| style="border-right: medium none; border-top: medium none; border-left: medium none; border-bottom: medium none; border-collapse: collapse" border="1" | ||
|- | |- | ||
| style="border: 0.5pt solid windowtext; | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: windowtext 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="82" | | ||
'''Disorder''' | '''Disorder''' | ||
| style="border- | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="108" | | ||
'''Clinical''' | '''Clinical''' | ||
| style="border- | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="162" | | ||
'''1<sup>st</sup> line''' | '''1<sup>st</sup> line''' | ||
| style="border- | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="176" | | ||
'''Alternative''' | '''Alternative''' | ||
| style="border- | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="90" | | ||
'''Partner''' | '''Partner''' | ||
| style="border- | | style="border-right: windowtext 0.5pt solid; padding-right: 5.4pt; border-top: windowtext 0.5pt solid; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: windowtext 0.5pt solid" valign="top" width="108" | | ||
'''In Pregnancy''' | '''In Pregnancy''' | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''N. Gonorrhea'' | ''N. Gonorrhea'' | ||
Urethritis/ | Urethritis/ | ||
Cervicitis | Cervicitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
M: urethritis with d/c or simply dysuria;can be asymptomatic | M: urethritis with d/c or simply dysuria;can be asymptomatic | ||
F: purulent discharge; can be asymptomatic | F: purulent discharge; can be asymptomatic | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Ceftriaxone 125mg IM | Ceftriaxone 125mg IM | ||
OR | OR | ||
Cefixime (Suprax) 400mg po x1 | Cefixime (Suprax) 400mg po x1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii | Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii | ||
OR | OR | ||
Spectinomycin 2g IM x 1 OR | Spectinomycin 2g IM x 1 OR | ||
Azithromycin 2g po x 1 | Azithromycin 2g po x 1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Treat and abstinence x 7d after both treated | Treat and abstinence x 7d after both treated | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
CTX 125mg IM x 1 | CTX 125mg IM x 1 | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''N. Gonorrhea'' | ''N. Gonorrhea'' | ||
Conjunctivitis | Conjunctivitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
2-5d after birth | 2-5d after birth | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Erythromycin ophthalmic 0.5% x1 | Erythromycin ophthalmic 0.5% x1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Tetracycline ophthalmic 1% x1 | Tetracycline ophthalmic 1% x1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''N. Gonorrhea'' | ''N. Gonorrhea'' | ||
Disseminated | Disseminated | ||
(DGI) | (DGI) | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Petechial, pustular acral skin lesions, | Petechial, pustular acral skin lesions, | ||
Asymmetrical arthralgias, tenosynovitis, | Asymmetrical arthralgias, tenosynovitis, | ||
Septic arthritis | Septic arthritis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
CTX 1g IM/IV q24 | CTX 1g IM/IV q24 | ||
-continue x24-48h until improvement | -continue x24-48h until improvement | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Cefotax 1g IV q8 | Cefotax 1g IV q8 | ||
Spectinomycin 2g IV q12 | Spectinomycin 2g IV q12 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''Chlamydia Trachomatis'' | ''Chlamydia Trachomatis'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
M: urethritis with d/c or simply dysuria; can be asymptomatic | M: urethritis with d/c or simply dysuria; can be asymptomatic | ||
F: purulent discharge or cervical bleeding; can be asymptomatic | F: purulent discharge or cervical bleeding; can be asymptomatic | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Azithromycin 1g po x1 | Azithromycin 1g po x1 | ||
OR | OR | ||
Doxycycline 100mg po bid x 7d | Doxycycline 100mg po bid x 7d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Erythromycin base 500mg po qid x 7d OR | Erythromycin base 500mg po qid x 7d OR | ||
Oflox 300mg po bid x 7d | Oflox 300mg po bid x 7d | ||
OR | OR | ||
Levoflox 500mg po qd x 7days | Levoflox 500mg po qd x 7days | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Treat and abstinence x 7d after both treated | Treat and abstinence x 7d after both treated | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Azithromycin 1g po x1 or | Azithromycin 1g po x1 or | ||
Amoxicillin 500mg po tid x 7d | Amoxicillin 500mg po tid x 7d | ||
Or | Or | ||
Erythro | Erythro | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''Chlamydia'' | ''Chlamydia'' | ||
''Trachomatis'' | ''Trachomatis'' | ||
Conjunctivitis | Conjunctivitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea | 5-12d after birth; silver nitrate ophthalmic only rx gonorrhea | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Erythromycin base 50mg/kg/day PO / 4 doses x14days | Erythromycin base 50mg/kg/day PO / 4 doses x14days | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''Chlamydia Trachomatis'' | ''Chlamydia Trachomatis'' | ||
Pneumonia | Pneumonia | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia | 1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Erythromycin base 50mg/kg/day po / 4 doses x14days | Erythromycin base 50mg/kg/day po / 4 doses x14days | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
''Trichamonas vaginalis'' | ''Trichamonas vaginalis'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
White, thick discharge | White, thick discharge | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Metronidazole 2g po x 1 | Metronidazole 2g po x 1 | ||
OR | OR | ||
Tinidazole 2g po x 1 | Tinidazole 2g po x 1 | ||
PLUS | PLUS | ||
Azithro 1g po x 1 | Azithro 1g po x 1 | ||
-intravag cream not recommended | -intravag cream not recommended | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence | Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence | ||
OR | OR | ||
Topical clotrimazole for metronidazole allergy– not as effective | Topical clotrimazole for metronidazole allergy– not as effective | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Metronidazole 2g po x 1 | Metronidazole 2g po x 1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Rx only if symptomatic but rx partner | Rx only if symptomatic but rx partner | ||
1<sup>st</sup> trimester, Clotrimazole 100mg hs for 7days | 1<sup>st</sup> trimester, Clotrimazole 100mg hs for 7days | ||
After 1<sup>st</sup> trimester,<span> </span> Metronidazole 2g po x 1 | After 1<sup>st</sup> trimester,<span> </span>Metronidazole 2g po x 1 | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Bacterial Vaginosis | Bacterial Vaginosis | ||
''Lactobacillus'' | ''Lactobacillus'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
White, fishy discharge | White, fishy discharge | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Metronidazole 500mg po bid for 7d | Metronidazole 500mg po bid for 7d | ||
OR | OR | ||
0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d | 0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d | ||
OR | OR | ||
2% Clindamycin cream 5g qd for 5d | 2% Clindamycin cream 5g qd for 5d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Clindamycin 300mg po bid for 7d (recurrence) | Clindamycin 300mg po bid for 7d (recurrence) | ||
OR | OR | ||
Clindamycin ovules 100mg intravaginally qhs x 3d | Clindamycin ovules 100mg intravaginally qhs x 3d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Exam for STD | Exam for STD | ||
No rx if nl | No rx if nl | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
1<sup>st</sup> trimester, metronidazole 250mg po tid x7d | 1<sup>st</sup> trimester, metronidazole 250mg po tid x7d | ||
After 1<sup>st</sup> trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d | After 1<sup>st</sup> trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Candidiasis | Candidiasis | ||
(''Candida albicans''<span style="font-style: normal">)</span> | (''Candida albicans''<span style="font-style: normal">)</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Cottage cheese; | Cottage cheese; | ||
DM or immunocompromised | DM or immunocompromised | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Butoconazole 2% cream 5g intravaginally for 3d | Butoconazole 2% cream 5g intravaginally for 3d | ||
OR | OR | ||
Butaconazole-sustained 2% intravag x1 | Butaconazole-sustained 2% intravag x1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Clotrimazole 1%<span> </span> 5g cream intravaginally for 7-14d (OTC) | Clotrimazole 1%<span> </span>5g cream intravaginally for 7-14d (OTC) | ||
OR | OR | ||
Clotrimazole 100mg intravag tablet x 7d | Clotrimazole 100mg intravag tablet x 7d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Candicidal cream if dermatitis present | Candicidal cream if dermatitis present | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Avoid fluconazole and ketoconazole. | Avoid fluconazole and ketoconazole. | ||
Rx with cream for 7d | Rx with cream for 7d | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Chancroid | Chancroid | ||
(''H. ducreyi''<span style="font-style: normal">)</span> | (''H. ducreyi''<span style="font-style: normal">)</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Painful ulcers with suppurative LAD | Painful ulcers with suppurative LAD | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Azithromycin 1g PO x 1 | Azithromycin 1g PO x 1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
CTX 250mg IM x1 | CTX 250mg IM x1 | ||
Cipro 500mg PO bid x 3days | Cipro 500mg PO bid x 3days | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
See CDC | See CDC | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
CTX | CTX | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Granuloma Inguinale<span> </span> (Donvanosis) | Granuloma Inguinale<span> </span>(Donvanosis) | ||
''Klebsiella granulomatis'' | ''Klebsiella granulomatis'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Painless lesions without LAD | Painless lesions without LAD | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Doxycycline 100mg PO BID x 3wks and until all lesions heald | Doxycycline 100mg PO BID x 3wks and until all lesions heald | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Aizthromycin 1g po q week | Aizthromycin 1g po q week | ||
Ciproflox 750mg PO bid x 3 weeks | Ciproflox 750mg PO bid x 3 weeks | ||
Bactrim DS 1tab PO BID x 3 wks | Bactrim DS 1tab PO BID x 3 wks | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
same | same | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Erythromycin base 500mg po qid x 3wks | Erythromycin base 500mg po qid x 3wks | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Lymphogranuloma Venereum (LGV) | Lymphogranuloma Venereum (LGV) | ||
''C. trach'' <span style="font-style: normal">serovars L1-L3</span> | ''C. trach'' <span style="font-style: normal">serovars L1-L3</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Tender, unilateral LAD; can lead to proctitis, fistulas | Tender, unilateral LAD; can lead to proctitis, fistulas | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Doxycycline 100mg po bid x 3 weeks | Doxycycline 100mg po bid x 3 weeks | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Erythromycin base 500mg po qid x 3wks | Erythromycin base 500mg po qid x 3wks | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
Treat within 60days of exposure with standard Chlamydia Rx | Treat within 60days of exposure with standard Chlamydia Rx | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Erythromycin base 500mg po qid x 3wks | Erythromycin base 500mg po qid x 3wks | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Chancre- | Chancre- | ||
Primary | Primary | ||
Syphilis | Syphilis | ||
(''T. pallidum''<span style="font-style: normal">)</span> | (''T. pallidum''<span style="font-style: normal">)</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Painless ulcer, chancre | Painless ulcer, chancre | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Benzathine Penicillin G 1.2million U IM x1 | Benzathine Penicillin G 1.2million U IM x1 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Doxycycline 100mg po bid x 14d | Doxycycline 100mg po bid x 14d | ||
Tetracycline 500mg po qid x 14d | Tetracycline 500mg po qid x 14d | ||
CTX 1g IM/IV x 8-10d | CTX 1g IM/IV x 8-10d | ||
Azithromycin 2g po x 1? | Azithromycin 2g po x 1? | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
See CDC | See CDC | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Penicillin; if allergic desensitize | Penicillin; if allergic desensitize | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Secondary Syphilis | Secondary Syphilis | ||
(''T. pallidum''<span style="font-style: normal">)</span> | (''T. pallidum''<span style="font-style: normal">)</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Skin rash, mucocutaneous lesions, LAD | Skin rash, mucocutaneous lesions, LAD | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
See CDC | See CDC | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Latent Syphilis | Latent Syphilis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Seroreactivity without other evidence of disease | Seroreactivity without other evidence of disease | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
''Early'' | ''Early'' | ||
''Late'' | ''Late'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Doxycycline 100mg po bid x 28d | Doxycycline 100mg po bid x 28d | ||
Tetracycline 500mg po qid x 28d | Tetracycline 500mg po qid x 28d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
See CDC | See CDC | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Tertiary Syphilis | Tertiary Syphilis | ||
(''T. pallidum''<span style="font-style: normal">)</span> | (''T. pallidum''<span style="font-style: normal">)</span> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Cardiac (aortitis), ophtho (iritis, uveitis), gumma | Cardiac (aortitis), ophtho (iritis, uveitis), gumma | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Benzathine<span> </span> Penicillin G 2.4million U IM qweek x 3 | Benzathine<span> </span>Penicillin G 2.4million U IM qweek x 3 | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | | ||
See CDC | See CDC | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Neurosyphilis | Neurosyphilis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Meningitis, syphilitic eye disease | Meningitis, syphilitic eye disease | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days | Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid<span> </span> | Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid<span> </span> | ||
BOTH for 10-14d | BOTH for 10-14d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
HSV (1<sup>st</sup> episode) | HSV (1<sup>st</sup> episode) | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Vesilcular rash | Vesilcular rash | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Acyclovir 400mg po TID x 7-10day | Acyclovir 400mg po TID x 7-10day | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Famciclovir 250mg po TID x 7-10d | Famciclovir 250mg po TID x 7-10d | ||
Valacyclovir 1g PO BID x 7-10d | Valacyclovir 1g PO BID x 7-10d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
HSV (suppressive) | HSV (suppressive) | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Acyclovir 400mg PO BID | Acyclovir 400mg PO BID | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Famciclovir 250mg po BID | Famciclovir 250mg po BID | ||
Valacyclovir 500mg PO qday | Valacyclovir 500mg PO qday | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Epididymitis | Epididymitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Pain, swelling, inflammation of the epididymis | Pain, swelling, inflammation of the epididymis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
CTX 250mg IM + Doxycyline 100mg po bid x 10d | CTX 250mg IM + Doxycyline 100mg po bid x 10d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Oflox 300mg<span> </span> po bid x 10d + levoflox 500mg po qday x 10d | Oflox 300mg<span> </span>po bid x 10d + levoflox 500mg po qday x 10d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Epididymorchitis | Epididymorchitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Proctitis | Proctitis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Inflammation of the rectum (distal 10-12cm) | Inflammation of the rectum (distal 10-12cm) | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
CTX 125mg IM x1 + Doxy 100mg po bid x 7d | CTX 125mg IM x1 + Doxy 100mg po bid x 7d | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
PID | PID | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP | Sexually active, no other sources and: CMT OR uterine OR adnexal TTP | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Outpt: | Outpt: | ||
Ceftriaxone 250mg IM x1 | Ceftriaxone 250mg IM x1 | ||
OR | OR | ||
Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose | Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose | ||
OR | OR | ||
Other parenteral 3<sup>rd</sup> gen cephalosporin eg ceftizoxime or cefotaxime | Other parenteral 3<sup>rd</sup> gen cephalosporin eg ceftizoxime or cefotaxime | ||
PLUS | PLUS | ||
Doxy 100mg po bid x14d | Doxy 100mg po bid x14d | ||
+/- | +/- | ||
Metronidazole 500mg po bid x 14d | Metronidazole 500mg po bid x 14d | ||
Parenteral: | Parenteral: | ||
Cefotetan 2g IV q12h | Cefotetan 2g IV q12h | ||
OR | OR | ||
Cefoxitin 2g IV q6h | Cefoxitin 2g IV q6h | ||
PLUS | PLUS | ||
Doxycyline 100mg IV or PO q12 | Doxycyline 100mg IV or PO q12 | ||
(''similar bioavailability)'' | (''similar bioavailability)'' | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Outpt: | Outpt: | ||
Oflox 400mg po bid x 14d | Oflox 400mg po bid x 14d | ||
OR | OR | ||
Levofloxacin 500mg po qday x 14d | Levofloxacin 500mg po qday x 14d | ||
+/- | +/- | ||
Metronidazole 500mg po bid x 14d | Metronidazole 500mg po bid x 14d | ||
Parenteral: | Parenteral: | ||
Clinda 900mg IV q8h | Clinda 900mg IV q8h | ||
PLUS | PLUS | ||
Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted | Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted | ||
Oflox 400mg IV q12h | Oflox 400mg IV q12h | ||
OR | OR | ||
Levoflox 500mg IV qday | Levoflox 500mg IV qday | ||
+/- | +/- | ||
Metro 500mg IVq8h | Metro 500mg IVq8h | ||
OR | OR | ||
Unasyn 3g IV q6h | Unasyn 3g IV q6h | ||
PLUS | PLUS | ||
Doxy 100mg IV or PO q12h | Doxy 100mg IV or PO q12h | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Scabies | Scabies | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Crusted rash, intertiginous areas | Crusted rash, intertiginous areas | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h | Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Ivermectin 200mcg/kg PO, repeated in 2weeks | Ivermectin 200mcg/kg PO, repeated in 2weeks | ||
Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse | Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|- | |- | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: 0.5pt solid; width: 81.9pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="82" | | ||
Pediculosis Pubis | Pediculosis Pubis | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | | ||
Puritic genitalia | Puritic genitalia | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 2.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="162" | | ||
Permethrin 1% cream: apply to affected areas x 10mins then wash off | Permethrin 1% cream: apply to affected areas x 10mins then wash off | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 175.5pt; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="176" | | ||
Malathion lotion 0.5% apply x 8-12h then rinse | Malathion lotion 0.5% apply x 8-12h then rinse | ||
OR | OR | ||
Ivermectin<span> </span> 250mcg/kg PO repeated in 2 weeks | Ivermectin<span> </span>250mcg/kg PO repeated in 2 weeks | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.25in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="90" | <br> | ||
| style="border- | | style="border-right: 0.5pt solid; padding-right: 5.4pt; border-top: medium none; padding-left: 5.4pt; padding-bottom: 0in; border-left: medium none; width: 1.5in; padding-top: 0in; border-bottom: 0.5pt solid" valign="top" width="108" | <br> | ||
|} | |} | ||
†Test for HIV, syphilis | †Test for HIV, syphilis | ||
== Source == | == Source == | ||
DeBonis | DeBonis | ||
Adapted from CDC 2006 | Adapted from CDC 2006 | ||
[[Category:GU]] | [[Category:GU]] [[Category:ID]] [[Category:OB/GYN]] | ||
[[Category:ID]] | |||
[[Category:OB/GYN]] | |||
Revisión del 17:39 7 jul 2011
Chart
|
Disorder |
Clinical |
1st line |
Alternative |
Partner |
In Pregnancy |
|
N. Gonorrhea Urethritis/ Cervicitis |
M: urethritis with d/c or simply dysuria;can be asymptomatic F: purulent discharge; can be asymptomatic |
Ceftriaxone 125mg IM OR Cefixime (Suprax) 400mg po x1 |
Cipro 500po x 1 – not acceptable in MSM, travel, California, Hawaii OR Spectinomycin 2g IM x 1 OR Azithromycin 2g po x 1 |
Treat and abstinence x 7d after both treated |
CTX 125mg IM x 1 |
|
N. Gonorrhea Conjunctivitis |
2-5d after birth |
Erythromycin ophthalmic 0.5% x1 |
Tetracycline ophthalmic 1% x1 |
||
|
N. Gonorrhea Disseminated (DGI) |
Petechial, pustular acral skin lesions, Asymmetrical arthralgias, tenosynovitis, Septic arthritis |
CTX 1g IM/IV q24 -continue x24-48h until improvement |
Cefotax 1g IV q8 Spectinomycin 2g IV q12 |
||
|
Chlamydia Trachomatis |
M: urethritis with d/c or simply dysuria; can be asymptomatic F: purulent discharge or cervical bleeding; can be asymptomatic |
Azithromycin 1g po x1 OR Doxycycline 100mg po bid x 7d |
Erythromycin base 500mg po qid x 7d OR Oflox 300mg po bid x 7d OR Levoflox 500mg po qd x 7days |
Treat and abstinence x 7d after both treated |
Azithromycin 1g po x1 or Amoxicillin 500mg po tid x 7d Or Erythro |
|
Chlamydia Trachomatis Conjunctivitis |
5-12d after birth; silver nitrate ophthalmic only rx gonorrhea |
Erythromycin base 50mg/kg/day PO / 4 doses x14days |
|||
|
Chlamydia Trachomatis Pneumonia |
1-3months; afebrile, staccato cough with diffuse infiltrates on CXR; peripheral eosinophilia |
Erythromycin base 50mg/kg/day po / 4 doses x14days |
|||
|
Trichamonas vaginalis |
White, thick discharge |
Metronidazole 2g po x 1 OR Tinidazole 2g po x 1 PLUS Azithro 1g po x 1 -intravag cream not recommended |
Metronidazole 500mg bid for 7days; 1-2g po qday x 7d if recurrence OR Topical clotrimazole for metronidazole allergy– not as effective |
Metronidazole 2g po x 1 |
Rx only if symptomatic but rx partner 1st trimester, Clotrimazole 100mg hs for 7days After 1st trimester, Metronidazole 2g po x 1 |
|
Bacterial Vaginosis Lactobacillus |
White, fishy discharge |
Metronidazole 500mg po bid for 7d OR 0.75% Metronidazole gel (one full applicator 5g) intravaginal qd for 5d OR 2% Clindamycin cream 5g qd for 5d |
Clindamycin 300mg po bid for 7d (recurrence) OR Clindamycin ovules 100mg intravaginally qhs x 3d |
Exam for STD No rx if nl |
1st trimester, metronidazole 250mg po tid x7d After 1st trimester, 500mg po bid for 7days or 250mg po tid x7d or Clinda 300mg po bid x 7d |
|
Candidiasis (Candida albicans) |
Cottage cheese; DM or immunocompromised |
Butoconazole 2% cream 5g intravaginally for 3d OR Butaconazole-sustained 2% intravag x1 |
Clotrimazole 1% 5g cream intravaginally for 7-14d (OTC) OR Clotrimazole 100mg intravag tablet x 7d |
Candicidal cream if dermatitis present |
Avoid fluconazole and ketoconazole. Rx with cream for 7d |
|
Chancroid (H. ducreyi) |
Painful ulcers with suppurative LAD |
Azithromycin 1g PO x 1 |
CTX 250mg IM x1 Cipro 500mg PO bid x 3days |
See CDC |
CTX |
|
Granuloma Inguinale (Donvanosis) Klebsiella granulomatis |
Painless lesions without LAD |
Doxycycline 100mg PO BID x 3wks and until all lesions heald |
Aizthromycin 1g po q week Ciproflox 750mg PO bid x 3 weeks Bactrim DS 1tab PO BID x 3 wks |
same |
Erythromycin base 500mg po qid x 3wks |
|
Lymphogranuloma Venereum (LGV) C. trach serovars L1-L3 |
Tender, unilateral LAD; can lead to proctitis, fistulas |
Doxycycline 100mg po bid x 3 weeks |
Erythromycin base 500mg po qid x 3wks |
Treat within 60days of exposure with standard Chlamydia Rx |
Erythromycin base 500mg po qid x 3wks |
|
Chancre- Primary Syphilis (T. pallidum) |
Painless ulcer, chancre |
Benzathine Penicillin G 1.2million U IM x1 |
Doxycycline 100mg po bid x 14d Tetracycline 500mg po qid x 14d CTX 1g IM/IV x 8-10d Azithromycin 2g po x 1? |
See CDC |
Penicillin; if allergic desensitize |
|
Secondary Syphilis (T. pallidum) |
Skin rash, mucocutaneous lesions, LAD |
See CDC |
|||
|
Latent Syphilis |
Seroreactivity without other evidence of disease |
Early Late |
Doxycycline 100mg po bid x 28d Tetracycline 500mg po qid x 28d |
See CDC |
|
|
Tertiary Syphilis (T. pallidum) |
Cardiac (aortitis), ophtho (iritis, uveitis), gumma |
Benzathine Penicillin G 2.4million U IM qweek x 3 |
See CDC |
||
|
Neurosyphilis |
Meningitis, syphilitic eye disease |
Aqueous crystalline penicillin G 18-24million units/d administered as 3-4million units IV q4h or continuous infusion x 10-14days |
Procaine penicillin 2.4million units IM qday + Probenecid 500mg po qid BOTH for 10-14d |
||
|
HSV (1st episode) |
Vesilcular rash |
Acyclovir 400mg po TID x 7-10day |
Famciclovir 250mg po TID x 7-10d Valacyclovir 1g PO BID x 7-10d |
||
|
HSV (suppressive) |
Acyclovir 400mg PO BID |
Famciclovir 250mg po BID Valacyclovir 500mg PO qday |
|||
|
Epididymitis |
Pain, swelling, inflammation of the epididymis |
CTX 250mg IM + Doxycyline 100mg po bid x 10d |
Oflox 300mg po bid x 10d + levoflox 500mg po qday x 10d |
||
|
Epididymorchitis |
|||||
|
Proctitis |
Inflammation of the rectum (distal 10-12cm) |
CTX 125mg IM x1 + Doxy 100mg po bid x 7d |
|||
|
PID |
Sexually active, no other sources and: CMT OR uterine OR adnexal TTP |
Outpt: Ceftriaxone 250mg IM x1 OR Cefoxitin 2g IM in a single dose and probenecid 1g orally administered concurrently in single dose OR Other parenteral 3rd gen cephalosporin eg ceftizoxime or cefotaxime PLUS Doxy 100mg po bid x14d +/- Metronidazole 500mg po bid x 14d Parenteral: Cefotetan 2g IV q12h OR Cefoxitin 2g IV q6h PLUS Doxycyline 100mg IV or PO q12 (similar bioavailability) |
Outpt: Oflox 400mg po bid x 14d OR Levofloxacin 500mg po qday x 14d +/- Metronidazole 500mg po bid x 14d Parenteral: Clinda 900mg IV q8h PLUS Gent load 2mgkg IV; maintenance 1.5mg/kg q8h; single daily dosing may be substituted Oflox 400mg IV q12h OR Levoflox 500mg IV qday +/- Metro 500mg IVq8h OR Unasyn 3g IV q6h PLUS Doxy 100mg IV or PO q12h |
||
|
Scabies |
Crusted rash, intertiginous areas |
Permethrin 5% cream applied to all areas of body from neck down and rinsed off after 8-14h |
Ivermectin 200mcg/kg PO, repeated in 2weeks Lindane (1%) 1 ounce of lotion of 30g of cream applied in thin layer all over from neck down x 8 hours then rinse |
||
|
Pediculosis Pubis |
Puritic genitalia |
Permethrin 1% cream: apply to affected areas x 10mins then wash off |
Malathion lotion 0.5% apply x 8-12h then rinse OR Ivermectin 250mcg/kg PO repeated in 2 weeks |
†Test for HIV, syphilis
Source
DeBonis
Adapted from CDC 2006
